发明名称 Use of IFN-alpha and amantadine for the treatment of chronic hepatitis C
摘要 The present invention provides a method for treating chronic hepatitis C infections in patients in need of such treatment comprising administering an amount of IFN-alpha in association with an amount of amantadine effective to treat hepatitis C. In accordance with the invention, IFN-alpha and amantadine are administered at the same time or sequentially. The present invention also provides a kit for treating a hepatitis C infection containing IFN-alpha and amantadine in suitable dosage forms for administering the combination therapy.
申请公布号 ZA9808519(B) 申请公布日期 1999.03.18
申请号 ZA19980008519 申请日期 1998.09.17
申请人 F.HOFFMANN-LA ROCHE AG. 发明人 FRIEDERIKE ZAHM
分类号 A61K38/21;A61P1/16;A61P31/12 主分类号 A61K38/21
代理机构 代理人
主权项
地址